Neurocrine Biosciences (NASDAQ:NBIX) Q3 2026 Earnings Call
Neurocrine Biosciences (NASDAQ:NBIX) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
- Period
- Q3 2026 earnings call
- Date
- Mon, Nov 2, 2026, 4:30 PM ET
On 6ix: 6ix.com/event/neurocrine-biosciences-inc-nbix-q3-2026-earnings-call
Latest news releases
- NASDAQ:NBIX — Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-'567 in Adults with Alzheimer's Disease · Tue, Oct 20, 2026
- NASDAQ:NBIX — Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia · Fri, Oct 16, 2026